Dr Reddy’s Laboratories Ltd., a global pharmaceutical company, has entered into a license agreement with Pharmazz, Inc. (Pharmazz), a US based biopharmaceutical company, to commercialise the ...

Centhaquine, a new drug to treat patients who have severe blood or fluid loss, significantly improved outcomes and reduced death rate among shock patients. Centhaquine significantly improved survival ...

Centhaquine is a first-of-its-kind resuscitative agent to treat hypovolemic shock by increasing stroke volume and cardiac output due to an increase in (preload) venous blood return to the heart and a ...

Septic shock results in approximately 350,000 deaths in the U.S. each year, the leading cause of hospital-related mortality and a major financial burden for the medical system Six trial sites with ...

Dr Reddy's and Pharmazz are collaborating to roll out Centhaquine, a revolutionary resuscitative agent for hypovolemic shock in India. The drug aims to improve cardiac output and blood circulation, ...

Septic shock results in approximately 350,000 deaths in the U.S. each year, the leading cause of hospital-related mortality and a major financial burden for the medical system Absolute hypovolemia ...

KANSAS CITY, Mo.--(BUSINESS WIRE)--Vivacelle Bio, Inc., a privately held life science company focused on the development of treatments for hypovolemia in shock including septic shock and hemorrhagic ...

WILLOWBROOK, Ill., Feb. 7, 2020 /PRNewswire/ -- Pharmazz, Inc., a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat patients in critical care, ...

An autopsy on the body of the Hungarian mother-of-two, who was yesterday stabbed by her partner with a pair of scissors, found that she died due to hypovolemic shock caused by the stab wounds, the ...